pubmed-article:8368159 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8368159 | lifeskim:mentions | umls-concept:C0004096 | lld:lifeskim |
pubmed-article:8368159 | lifeskim:mentions | umls-concept:C0599779 | lld:lifeskim |
pubmed-article:8368159 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
pubmed-article:8368159 | lifeskim:mentions | umls-concept:C0007578 | lld:lifeskim |
pubmed-article:8368159 | pubmed:dateCreated | 1993-10-7 | lld:pubmed |
pubmed-article:8368159 | pubmed:abstractText | Cell surface adhesive glycoproteins are principal regulators of nearly all aspects of immune/inflammatory responses. Using monoclonal antibodies to individual adhesion molecules, the expression and contribution of specific molecules in the pathogenesis of allergen-induced airway hyperresponsiveness in monkeys has been deciphered. Results confirm the importance of cell adhesion and demonstrate that antagonism of a single adhesion molecule may provide a novel therapeutic approach. | lld:pubmed |
pubmed-article:8368159 | pubmed:language | eng | lld:pubmed |
pubmed-article:8368159 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8368159 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8368159 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8368159 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8368159 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8368159 | pubmed:issn | 0379-0363 | lld:pubmed |
pubmed-article:8368159 | pubmed:author | pubmed-author:LettsL GLG | lld:pubmed |
pubmed-article:8368159 | pubmed:author | pubmed-author:WegnerC DCD | lld:pubmed |
pubmed-article:8368159 | pubmed:author | pubmed-author:GundelR HRH | lld:pubmed |
pubmed-article:8368159 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8368159 | pubmed:volume | 43 | lld:pubmed |
pubmed-article:8368159 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8368159 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8368159 | pubmed:pagination | 151-62 | lld:pubmed |
pubmed-article:8368159 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:8368159 | pubmed:meshHeading | pubmed-meshheading:8368159-... | lld:pubmed |
pubmed-article:8368159 | pubmed:meshHeading | pubmed-meshheading:8368159-... | lld:pubmed |
pubmed-article:8368159 | pubmed:meshHeading | pubmed-meshheading:8368159-... | lld:pubmed |
pubmed-article:8368159 | pubmed:meshHeading | pubmed-meshheading:8368159-... | lld:pubmed |
pubmed-article:8368159 | pubmed:meshHeading | pubmed-meshheading:8368159-... | lld:pubmed |
pubmed-article:8368159 | pubmed:meshHeading | pubmed-meshheading:8368159-... | lld:pubmed |
pubmed-article:8368159 | pubmed:meshHeading | pubmed-meshheading:8368159-... | lld:pubmed |
pubmed-article:8368159 | pubmed:meshHeading | pubmed-meshheading:8368159-... | lld:pubmed |
pubmed-article:8368159 | pubmed:meshHeading | pubmed-meshheading:8368159-... | lld:pubmed |
pubmed-article:8368159 | pubmed:meshHeading | pubmed-meshheading:8368159-... | lld:pubmed |
pubmed-article:8368159 | pubmed:year | 1993 | lld:pubmed |
pubmed-article:8368159 | pubmed:articleTitle | Efficacy of monoclonal antibodies against adhesion molecules in animal models of asthma. | lld:pubmed |
pubmed-article:8368159 | pubmed:affiliation | Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877. | lld:pubmed |
pubmed-article:8368159 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8368159 | pubmed:publicationType | Review | lld:pubmed |